Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Author(s):
Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Hoesel, R. van; Verweij, J.; Bonvalot, S.; Steward, W.P.; Gronchi, A.; Hogendoorn, P.C.W. (0000-0002-1513-8104); Litiere, S.; Marreaud, S.; Blay, J.Y.; Graaf, W.T.A. van der
Published
2014
Publication type
Article / Letter to editor
soft tissue sarcomaadjuvant chemotherapypredictive factorstreatment outcome
Date issued
2014-12-31
Language
English
Is part of
Annals of Oncology (2014), Vol. 25, no. 12, p. 2425-2432
hdl
1887/105330
doi
10.1093/annonc/mdu460